USL261 |
NAYZILAM |
MIDAZOLAM |
MIDAZOLAM CIV |
USL-261 |
DORMICUM® |
VERSED® |
BUCCOLAM |
DORMICUM |
MIDAZOLAMUM |
rxcui:6960 |
chembl:CHEMBL655 |
drugbank:00683 |
pubchem.compound:4192 |
chemidplus:59467-70-8 |
Drug Class | hypnotics and sedatives |
Drug Class | adjuvants, anesthesia |
Year of Approval | 1985 |
FDA Approval | 1985 |
Drug Class | small molecule |
Drug Indications | Hypnotics and Sedatives |
Drug Indications | Adjuvants, Anesthesia |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Novel drug target | Established target |
Trial Name | - |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Trial Name | - |
Novel drug target | Established target |
potentiator |
Novel drug target | Established target |
Trial Name | - |
MIDAZOLAM | Primary Drug Name |
Year of Approval | 1985 |
Drug Class | adjuvants, anesthesia |
Drug Class | hypnotics and sedatives |
Drug Indications | Adjuvants, Anesthesia |
Drug Indications | Hypnotics and Sedatives |
Drug Class | small molecule |
CHEMBL655 | ChEMBL Drug ID |
C654 | NCI drug code |
D0U6LM | TTD Drug ID |